Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: final results of a randomised phase III study (EORTC 18032). (Q34629364)
Jump to navigation
Jump to search
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: final results of a randomised phase III study (EORTC 18032). |
scientific article |
Statements
1 reference
Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: final results of a randomised phase III study (EORTC 18032). (English)
1 reference
Alexander M M Eggermont
1 reference
Dirk Schadendorf
1 reference
Stefan Suciu
1 reference
Ulrich Keilholz
1 reference
Poulam M Patel
1 reference
Laurent Mortier
1 reference
Wim H Kruit
1 reference
Uwe Trefzer
1 reference
Cornelis J A Punt
1 reference
Reinhard Dummer
1 reference
Neville Davidson
1 reference
Juergen Becker
1 reference
Robert Conry
1 reference
John A Thompson
1 reference
Wen-Jen Hwu
1 reference
Kristel Engelen
1 reference
Sanjiv S Agarwala
1 reference
Alain Spatz
1 reference
EORTC Melanoma Group
1 reference
1 reference
Identifiers
1 reference